Skip to main content
Erschienen in: Pediatric Cardiology 4/2014

01.04.2014 | Original Article

Variability of M-Mode Versus Two-Dimensional Echocardiography Measurements in Children With Dilated Cardiomyopathy

verfasst von: Caroline K. Lee, Renee Margossian, Lynn A. Sleeper, Charles E. Canter, Shan Chen, Lloyd Y. Tani, Girish Shirali, Anita Szwast, Elif Seda Selamet Tierney, M. Jay Campbell, Fraser Golding, Yanli Wang, Karen Altmann, Steven D. Colan, for the Pediatric Heart Network Investigators

Erschienen in: Pediatric Cardiology | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Abstract

M-mode and 2-dimensional (2D) echocardiographic imaging are routinely used to quantify left-ventricular (LV) size and function in pediatric patients with dilated cardiomyopathy (DCM). The reproducibility of and correlation between these techniques are unknown. This analysis sought to compare interreader, intrareader, and interacquisition reproducibility of M-mode versus 2D measurements in pediatric DCM patients. The Ventricular Volume Variability study of the Pediatric Heart Network is a multicenter, prospective, observational study assessing the course of chronic DCM in children. Two sonographers performed baseline image acquisitions locally, and two readers performed measurements at the echocardiographic core laboratory. One reader repeated measurements 1 month later. These data were used to assess reproducibility and agreement between M-mode and 2D measurements. One hundred sixty-nine subjects were enrolled. M-mode had similar or greater reproducibility in both intrareader and interreader settings for LV dimensions, shortening fraction (SF), and most wall thicknesses. In contrast, 2D reproducibility was similar or better for nearly all variables in the interacquisition setting but not for SF. Interacquisition variability was approximately twice the intrareader variability. LV dimensions by either modality consistently had high reproducibility and had the highest agreement between modalities. In pediatric DCM patients, variability of linear echocardiographic assessment could be minimized by relying on a single reader and using a consistent method (M-mode or 2D) for serial measurements, preferably M-mode when SF is the primary variable of interest. Except for LV dimensions, M-mode and 2D values should not be used interchangeably due to poor agreement.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Alvarez JA, Wilkinson JD, Lipshultz SE (2007) Outcome predictors for pediatric dilated cardiomyopathy: a systematic review. Prog Pediatr Cardiol 23:25–32PubMedCentralCrossRefPubMed Alvarez JA, Wilkinson JD, Lipshultz SE (2007) Outcome predictors for pediatric dilated cardiomyopathy: a systematic review. Prog Pediatr Cardiol 23:25–32PubMedCentralCrossRefPubMed
2.
Zurück zum Zitat Blume ED, Canter CE, Spicer R, Gauvreau K, Colan S, Jenkins KJ (2006) Prospective single-arm protocol of carvedilol in children with ventricular dysfunction. Pediatr Cardiol 27:336–342CrossRefPubMed Blume ED, Canter CE, Spicer R, Gauvreau K, Colan S, Jenkins KJ (2006) Prospective single-arm protocol of carvedilol in children with ventricular dysfunction. Pediatr Cardiol 27:336–342CrossRefPubMed
3.
Zurück zum Zitat Colan SD, Shirali G, Margossian R, Gallagher D, Altmann K, Canter C et al (2012) The Ventricular Volume Variability Study of the Pediatric Heart Network: study design and impact of beat averaging and variable type on the reproducibility of echocardiographic measurements in children with chronic dilated cardiomyopathy. J Am Soc Echocardiogr 8:42–54 Colan SD, Shirali G, Margossian R, Gallagher D, Altmann K, Canter C et al (2012) The Ventricular Volume Variability Study of the Pediatric Heart Network: study design and impact of beat averaging and variable type on the reproducibility of echocardiographic measurements in children with chronic dilated cardiomyopathy. J Am Soc Echocardiogr 8:42–54
4.
Zurück zum Zitat Dai S, Ayres NA, Harrist RB, Bricker JT, Labarthe DR (1999) Validity of echocardiographic measurement in an epidemiological study: Project HeartBeat! Hypertension 34:234–241CrossRef Dai S, Ayres NA, Harrist RB, Bricker JT, Labarthe DR (1999) Validity of echocardiographic measurement in an epidemiological study: Project HeartBeat! Hypertension 34:234–241CrossRef
5.
Zurück zum Zitat Daubeney PE, Nugent AW, Chondros P, Carlin JB, Colan SD, Cheung M, National Australian Childhood Cardiomyopathy Study et al (2006) Clinical features and outcomes of childhood dilated cardiomyopathy: results from a national population-based study. Circulation 114:2671–2678CrossRefPubMed Daubeney PE, Nugent AW, Chondros P, Carlin JB, Colan SD, Cheung M, National Australian Childhood Cardiomyopathy Study et al (2006) Clinical features and outcomes of childhood dilated cardiomyopathy: results from a national population-based study. Circulation 114:2671–2678CrossRefPubMed
6.
Zurück zum Zitat Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I et al (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57:450–458CrossRefPubMed Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I et al (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57:450–458CrossRefPubMed
7.
Zurück zum Zitat Geelhoed MJ, Snijders SPE, Kleyburg-Linkers VE, Steegers EA, van Osch-Gevers L et al (2009) Reliability of echocardiographic measurements of left cardiac structures in healthy children. Cardiol Young 19:494–500CrossRefPubMed Geelhoed MJ, Snijders SPE, Kleyburg-Linkers VE, Steegers EA, van Osch-Gevers L et al (2009) Reliability of echocardiographic measurements of left cardiac structures in healthy children. Cardiol Young 19:494–500CrossRefPubMed
8.
Zurück zum Zitat Haycock GB, Schwartz GJ, Wisotsky DH (1978) Geometric method for measuring body surface area: a height-weight formula validated in infants, children, and adults. J Pediatr 93:62–66CrossRefPubMed Haycock GB, Schwartz GJ, Wisotsky DH (1978) Geometric method for measuring body surface area: a height-weight formula validated in infants, children, and adults. J Pediatr 93:62–66CrossRefPubMed
9.
Zurück zum Zitat Hsu DT, Canter CE (2010) Dilated cardiomyopathy and heart failure in children. Heart Fail Clin 6:415–432CrossRefPubMed Hsu DT, Canter CE (2010) Dilated cardiomyopathy and heart failure in children. Heart Fail Clin 6:415–432CrossRefPubMed
10.
Zurück zum Zitat Lewis AB (1994) Prognostic value of echocardiography in children with idiopathic dilated cardiomyopathy. Am Heart J 128:133–136CrossRefPubMed Lewis AB (1994) Prognostic value of echocardiography in children with idiopathic dilated cardiomyopathy. Am Heart J 128:133–136CrossRefPubMed
11.
Zurück zum Zitat Lipshultz SE, Easley KA, Orav EJ, Kaplan S, Starc TJ, Bricker JT et al (2001) Reliability of multicenter pediatric echocardiographic measurements of left ventricular structure and function: the prospective P2C2 HIV study. Circulation 104:310–316PubMedCentralCrossRefPubMed Lipshultz SE, Easley KA, Orav EJ, Kaplan S, Starc TJ, Bricker JT et al (2001) Reliability of multicenter pediatric echocardiographic measurements of left ventricular structure and function: the prospective P2C2 HIV study. Circulation 104:310–316PubMedCentralCrossRefPubMed
12.
Zurück zum Zitat Lopez L, Colan SD, Frommelt PC, Ensing GJ, Kendall K, Younoszai AK et al (2010) Recommendations for quantification methods during the performance of a pediatric echocardiogram: a report from the Pediatric Measurements Writing Group of the American Society of Echocardiography Pediatric and Congenital Heart Disease Council. J Am Soc Echocardiogr 23:465–495CrossRefPubMed Lopez L, Colan SD, Frommelt PC, Ensing GJ, Kendall K, Younoszai AK et al (2010) Recommendations for quantification methods during the performance of a pediatric echocardiogram: a report from the Pediatric Measurements Writing Group of the American Society of Echocardiography Pediatric and Congenital Heart Disease Council. J Am Soc Echocardiogr 23:465–495CrossRefPubMed
13.
Zurück zum Zitat Schieken RM (1987) Measurement of left ventricular wall mass in pediatric populations. Hypertension 9:47–52CrossRef Schieken RM (1987) Measurement of left ventricular wall mass in pediatric populations. Hypertension 9:47–52CrossRef
14.
Zurück zum Zitat Shaddy RE, Tani LY, Gidding SS, Pahl E, Orsmond GS, Gilbert EM et al (1999) Beta-blocker treatment of dilated cardiomyopathy with congestive heart failure in children: a multi-institutional experience. J Heart Lung Transplant 18:269–274CrossRefPubMed Shaddy RE, Tani LY, Gidding SS, Pahl E, Orsmond GS, Gilbert EM et al (1999) Beta-blocker treatment of dilated cardiomyopathy with congestive heart failure in children: a multi-institutional experience. J Heart Lung Transplant 18:269–274CrossRefPubMed
15.
Zurück zum Zitat Shaddy RE, Boucek MM, Hsu DT, Boucek RJ, Canter CE, Mahony L et al (2007) Carvedilol for children and adolescents with heart failure: a randomized controlled trial. JAMA 298:1171–1179CrossRefPubMed Shaddy RE, Boucek MM, Hsu DT, Boucek RJ, Canter CE, Mahony L et al (2007) Carvedilol for children and adolescents with heart failure: a randomized controlled trial. JAMA 298:1171–1179CrossRefPubMed
16.
Zurück zum Zitat Towbin JA, Lowe AM, Colan SD, Sleeper LA, Orav EJ, Clunie S et al (2006) Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA 296:1867–1976CrossRefPubMed Towbin JA, Lowe AM, Colan SD, Sleeper LA, Orav EJ, Clunie S et al (2006) Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA 296:1867–1976CrossRefPubMed
Metadaten
Titel
Variability of M-Mode Versus Two-Dimensional Echocardiography Measurements in Children With Dilated Cardiomyopathy
verfasst von
Caroline K. Lee
Renee Margossian
Lynn A. Sleeper
Charles E. Canter
Shan Chen
Lloyd Y. Tani
Girish Shirali
Anita Szwast
Elif Seda Selamet Tierney
M. Jay Campbell
Fraser Golding
Yanli Wang
Karen Altmann
Steven D. Colan
for the Pediatric Heart Network Investigators
Publikationsdatum
01.04.2014
Verlag
Springer US
Erschienen in
Pediatric Cardiology / Ausgabe 4/2014
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-013-0835-9

Weitere Artikel der Ausgabe 4/2014

Pediatric Cardiology 4/2014 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.